Related Experiment Video
Updated: May 14, 2026

05:58
Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
Published on: October 13, 2023
Protein-carbohydrate complex reveals circulating metastatic cells in a microfluidic assay
1KIST Europe, Campus E71, 66123 Saarbrucken, Germany. giuseppina.simone@unina.it
Small (Weinheim an Der Bergstrasse, Germany)
|February 13, 2013
Summary
This study developed a new assay to detect carbohydrate-protein interactions, specifically examining beta-galactosides and galectin-3. The assay can isolate metastatic colon cancer cells, advancing personalized medicine.
Area of Science:
- Glycomics and glycobiology
- Molecular interactions
- Biotechnology
Background:
- Carbohydrate sequencing reveals glycome complexity and biological functions.
- Carbohydrate-protein interactions are vital in mammalian physiology, including cell adhesion, metastasis, and signaling.
- Galectin-3, a protein linked to tumor progression and metastasis, is a key target in cancer research.
Purpose of the Study:
- To develop a novel assay for sensitive and selective detection of carbohydrate-protein interactions.
- To mimic the multivalency of biological complexes for accurate binding analysis.
- To investigate the binding of beta-galactosides with galectin-3.
Main Methods:
- Development of a new assay to detect carbohydrate-protein interactions.
- Examination of beta-galactoside and galectin-3 binding.
- Comparative binding experiments to determine molecular preferences.
- Assessment of assay efficiency based on receptor expression and interaction strength.
Main Results:
- The assay effectively detects and quantifies carbohydrate-protein interactions.
- Molecular binding preferences between beta-galactosides and galectin-3 were identified.
- Assay efficiency correlates with receptor expression and binding affinity.
- The assay demonstrated robustness in isolating metastatic cells from colon cancer patients.
Conclusions:
- The developed assay is a robust tool for studying carbohydrate-protein interactions.
- The assay can successfully isolate metastatic cells from colon cancer patients.
- This work paves the way for advancements in personalized medicine for cancer treatment.

